Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02892474 · ClinicalTrials.gov registry record

HCR vs. CABG Study

A clinical trial of Coronary Artery Disease, sponsored by Emory University.

Completed
Registry status
75
Enrollment target
1
Study location

NCT02892474: Completed study of Coronary Artery Disease, sponsored by Emory University.

NCT02892474 is a study of Coronary Artery Disease that has completed, run by Emory University. The registered enrollment target is 75 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02892474, a study of Coronary Artery Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to find out if hybrid coronary revascularization (HCR) and coronary artery bypass grafting (CABG) procedure outcomes are similar. HCR is a combination of surgery and catheter procedures to open up clogged heart arteries. CABG is a surgical procedure to open up clogged heart arteries.

Primary Outcome

Major adverse cardiac and cerebrovascular events (MACCE) will be assessed at 30 days and at one year after the index procedure. For the purpose of this trial, the components of MACCE include (1) all-cause mortality, (2) repeat revascularization, (3) stroke, and (4) myocardial infarction.

Conditions Studied

Coronary Artery Disease

Interventions

  • PROCEDURE Hybrid Coronary Revascularization (HCR)
  • PROCEDURE Coronary Artery Bypass Grafting (CABG)

Study Locations (1)

Georgia

  • Emory University Hospital Midtown - Atlanta

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2016-08
Est. Completion 2018-07-27
Emory University

1,208 total trials

What the finished NCT02892474 record still lists

NCT02892474 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Hybrid Coronary Revascularization (HCR) is the first listed.

NCT02892474 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT02892474 about?

NCT02892474 is a clinical study titled "HCR vs. CABG Study". The purpose of the study is to find out if hybrid coronary revascularization (HCR) and coronary artery bypass grafting (CABG) procedure outcomes are similar. HCR is a combination of surgery and catheter procedures to open up clogged heart arteries. CABG is a surgical procedure to open up clogged hea...

What is the current status of trial NCT02892474?

This trial is currently completed. The enrollment target is 75 participants. The study started on 2016-08. Estimated completion is 2018-07-27.

What conditions does trial NCT02892474 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT02892474?

The interventions under investigation include: Hybrid Coronary Revascularization (HCR) (PROCEDURE), Coronary Artery Bypass Grafting (CABG) (PROCEDURE).

Who is sponsoring clinical trial NCT02892474?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02892474 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02892474's enrollment target sits among peer trials

75 161st of 219 higher than 58 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02892474, the US trial registry maintained by the National Library of Medicine. NCT02892474 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.